This space retains a tiny amount of solution that does not get injected
It just shows up differently on the scale
Key Takeaways Foundayo (orforglipron) is the first oral GLP-1 receptor agonist that can be taken any time of day without food or water restrictions FDA approved April 1, 2026 for chronic weight management Average weight loss in the ATTAIN-1 trial was 11.2% at 72 weeks at the highest dose less than injectable Wegovy (14.9%) or Zepbound (20.2%) Its small-molecule structure allows consistent absorption regardless of what is in the stomach Side effect profile is similar to other GLP-1 medications primarily gastrointestinal Starting cost is approximately $25/month with commercial insurance + Lilly savings card, $149/month self-pay for the lowest dose Best suited for patients with needle aversion, complicated schedules, or those who struggled with oral Wegovys fasting requirements Not recommended for patients already responding well to injectable GLP-1s Cannot be combined with other GLP-1 medications References Eli Lilly and Company
Rated 4.6/5 by 36 verified customers 10mg (5mg/5mg) Ships Monday morning if ordered within 23 hrs 38 min
This information guides whether your optimal dose sits at 1.0 mg, 1.7 mg, or the full 2.4 mg weekly
These three main food types, known as macronutrients, are the building blocks for all GLP-1 balanced meals
